WuXi Biologics (Cayman) Inc.

BMV:2269 N Stock Report

Market Cap: Mex$132.7b

WuXi Biologics (Cayman) Future Growth

Future criteria checks 3/6

WuXi Biologics (Cayman) is forecast to grow earnings and revenue by 17.1% and 17.2% per annum respectively. EPS is expected to grow by 17.2% per annum. Return on equity is forecast to be 13.6% in 3 years.

Key information

17.1%

Earnings growth rate

17.2%

EPS growth rate

Life Sciences earnings growth0%
Revenue growth rate17.2%
Future return on equity13.6%
Analyst coverage

Good

Last updated15 Mar 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:2269 N - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202630,8177,8711,854N/A6
12/31/202525,5226,3242,350N/A30
12/31/202420,0324,786155N/A32
12/31/202316,8413,837374N/A28
6/30/202316,5544,152N/AN/AN/A
3/31/202315,9114,286N/AN/AN/A
12/31/202215,2694,420-3275,542N/A
9/30/202214,1794,251-6774,816N/A
6/30/202213,0904,081-1,0284,091N/A
3/31/202211,6903,735-2,0523,761N/A
12/31/202110,2903,388-3,0773,431N/A
9/30/20219,1833,092-4,0062,840N/A
6/30/20218,0752,795-4,9362,249N/A
3/31/20216,8442,242-4,5402,065N/A
12/31/20205,6121,689-4,1441,881N/A
9/30/20204,9671,494-4,0491,649N/A
6/30/20204,3211,300-3,9541,417N/A
3/31/20204,1521,157-2,9791,312N/A
12/31/20193,9841,014-2,0041,208N/A
9/30/20193,535922-1,3561,035N/A
6/30/20193,087831-708861N/A
3/31/20192,811731-810811N/A
12/31/20182,534631-912762N/A
9/30/20182,277520-1,004508N/A
6/30/20182,019410-1,096255N/A
3/31/20181,819331-712308N/A
12/31/20171,619253-327360N/A
9/30/20171,429177-248320N/A
6/30/20171,233149-100369N/A
3/31/20171,111145N/A226N/A
12/31/2016989141N/A82N/A
9/30/2016889171N/A162N/A
12/31/201555745N/A107N/A
12/31/201433242N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2269 N's forecast earnings growth (17.1% per year) is above the savings rate (7.7%).

Earnings vs Market: 2269 N's earnings (17.1% per year) are forecast to grow faster than the MX market (10% per year).

High Growth Earnings: 2269 N's earnings are forecast to grow, but not significantly.

Revenue vs Market: 2269 N's revenue (17.2% per year) is forecast to grow faster than the MX market (6.8% per year).

High Growth Revenue: 2269 N's revenue (17.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2269 N's Return on Equity is forecast to be low in 3 years time (13.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y